You are invited to take part in an afternoon seminar event for advanced therapy researchers on Wednesday 8 July 2020, 13.00-15.00. The event is hosted jointly by CGT Catapult, the University of Cambridge, the Cambridge Academy of Therapeutics Sciences and the Wellcome - MRC Cambridge Stem Cell Institute.
The virtual event comprises a series of talks and discussion on the key considerations for commercialisation and translation of cell and gene therapy research with a focus on stem cell technologies and understanding how to prepare and ensure commercial success for your advanced therapy projects.
Areas of focus include:
• addressing current and future pre-clinical ATMP development needs
• regulatory and reimbursement considerations
• addressing barriers to scale-up manufacturing.
Would like to receive tailored feedback from our team on your project idea or proposal? Please indicate this during the EventBrite registration process by giving a brief summary (100-150 words) of your project and questions you would like to discuss with CGT Catapult experts.
Virtual one-to-one meetings will be scheduled with CGT Catapult after the seminar at a mutually convenient time.
We hope you will be able to join us.
After registration via EventBrite, you will receive an access link to the virutal event up to one week before the event to the email address provided during registration.
